(Refiles to fix headline)
Dec 20 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd
* Says board approves unit Yaneng Biotechnology’s initial public offering (IPO) in Hong Kong
* Says expects Yaneng Biotechnology to issue 40 million shares
Source text in Chinese: bit.ly/1musFwD
Further company coverage: (Reporting by Hong Kong and Singapore newsrooms)
